We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


NanoScreen Transitions From Partnership to Corporation

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "NanoScreen Transitions From Partnership to Corporation"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

NanoScreen has announced that it has updated its corporate structure to better position itself for growth. Formerly known as Nanoscreen, LLC, the company is now NanoScreen, Inc. This change re ects the Company's commitment, knowledge and expertise in driving the growth needed to accelerate the future of the Life Sciences industry.

NanoScreen also announced a partnership with Advanced Precision Medicine, Inc., a local molecular diagnostics lab, to help revolutionize traditional medical practices through a suite of molecular diagnostics tests. "It is rewarding to see two technology companies connect and partner up to become leaders of integrated healthcare solutions," said Ernest Andrade, Executive Director of the Charleston Digital Corridor. "This is a prime example of community and talent coming together to grow our Life Sciences community."

"The changes we have made provide us with the exibility to serve new markets and expand our product portfolio. Our commitment to transform the modern Life Sciences laboratory remains unchanged. NanoScreen will continue to build its momentum by securing new capital and embarking on a new growth phase for the company," said Garey De Angelis, Chairman of NanoScreen.

"NanoScreen products and technologies have served as the backbone for research-advancing precision medicine applications since the completion of the Human Genome project." said Dean Sproles, newly appointed Chief Executive Officer of NanoScreen. "Launching the ORION automated liquid handling workstation will transform and accelerate biomarker discovery and laboratory automation initiatives around the globe."

The new name is effective immediately, and will be implemented across the company's products and services throughout the 2016 calendar year.